Literature DB >> 8040332

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

M Kawamura1, J W Heinecke, A Chait.   

Abstract

Oxidized lipoproteins may be important in the pathogenesis of atherosclerosis. Because diabetic subjects are particularly prone to vascular disease, and glucose autoxidation and protein glycation generate reactive oxygen species, we explored the role of glucose in lipoprotein oxidation. Glucose enhanced low density lipoprotein (LDL) oxidation at concentrations seen in the diabetic state. Conjugated dienes, thiobarbituric acid reactive substances, electrophoretic mobility, and degradation by macrophages were increased when LDL was modified in the presence of glucose. In contrast, free lysine groups and fibroblast degradation were reduced. Although loss of reactive lysine groups could be due to either oxidative modification or nonenzymatic glycation of apolipoprotein B-100, inhibition of lipid peroxidation by the metal chelator, diethylenetriamine pentaacetic acid, blocked the changes in free lysines. Thus, glycation of lysine residues is unlikely to account for the alterations in macrophage and fibroblast uptake of LDL modified in the presence of glucose. Glucose-mediated enhancement of LDL oxidation was partially blocked by superoxide dismutase and nearly completely inhibited by butylated hydroxytoluene. These findings indicate that glucose enhances LDL lipid peroxidation by an oxidative pathway involving superoxide and raise the possibility that the chronic hyperglycemia of diabetes accelerates lipoprotein oxidation, thereby promoting diabetic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040332      PMCID: PMC296157          DOI: 10.1172/JCI117396

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.

Authors:  M el-Saadani; H Esterbauer; M el-Sayed; M Goher; A Y Nassar; G Jürgens
Journal:  J Lipid Res       Date:  1989-04       Impact factor: 5.922

3.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells.

Authors:  J W Heinecke; H Rosen; L A Suzuki; A Chait
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

4.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

5.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.

Authors:  U P Steinbrecher; M Lougheed; W C Kwan; M Dirks
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

6.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing.

Authors:  J V Hunt; R T Dean; S P Wolff
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

7.  Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor.

Authors:  B H Chung; T Wilkinson; J C Geer; J P Segrest
Journal:  J Lipid Res       Date:  1980-03       Impact factor: 5.922

8.  Oxygen radical generation by Maillard compounds.

Authors:  M S Azevedo; J Raposo; J Falcão; G Fontes; C Manso
Journal:  J Diabet Complications       Date:  1988 Jan-Mar

9.  Glycation of proteins as a source of superoxide.

Authors:  P Gillery; J C Monboisse; F X Maquart; J P Borel
Journal:  Diabete Metab       Date:  1988 Jan-Feb

10.  Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages.

Authors:  M F Lopes-Virella; R L Klein; T J Lyons; H C Stevenson; J L Witztum
Journal:  Diabetes       Date:  1988-05       Impact factor: 9.461

View more
  37 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.

Authors:  T Kobayashi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes.

Authors:  Tharmarajan Ramprasath; Ponniah Senthil Murugan; Ellappan Kalaiarasan; Pannerselvam Gomathi; Andiappan Rathinavel; Govindan Sadasivam Selvam
Journal:  Mol Cell Biochem       Date:  2011-10-12       Impact factor: 3.396

Review 4.  Clinical significance of the physicochemical properties of LDL in type 2 diabetes.

Authors:  P G Scheffer; T Teerlink; R J Heine
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

5.  Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes.

Authors:  K Kamata; T Kobayashi
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 6.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.

Authors:  G O'Driscoll; D Green; J Rankin; K Stanton; R Taylor
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

8.  Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton's Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus.

Authors:  Chiou-Mee Kong; Arjunan Subramanian; Arijit Biswas; Walter Stunkel; Yap-Seng Chong; Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

9.  The initiation of free radical peroxidation of low-density lipoproteins by glucose and its metabolite methylglyoxal: a common molecular mechanism of vascular wall injure in atherosclerosis and diabetes.

Authors:  Vadim Lankin; Galina Konovalova; Alla Tikhaze; Konstantin Shumaev; Elena Kumskova; Margus Viigimaa
Journal:  Mol Cell Biochem       Date:  2014-07-05       Impact factor: 3.396

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.